Company Description
CUR (NASDAQ: CUR) is a publicly traded biotechnology company in the Health Technology sector.
CUR stock has gained 160.3% over the past year.
This page provides a comprehensive overview of CUR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+160.32%
Performance 1 year
$0.0
CUR (CUR) stock. Over the past 12 months, the stock has gained 160.3%.
Latest News
CUR has 1 recent news article. Key topics include clinical trial, covid-19. View all CUR news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
CUR Company Profile & Sector Positioning
CUR (CUR) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.